SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

23 May 2023 Evaluate
The revenue zoomed 24.42% to Rs. 351.99 millions for the quarter ended March 2023 as compared to Rs. 282.90 millions during the corresponding quarter last year.Net profit surges 84.28% to Rs. 63.54  millions  from Rs. 34.48 millions in the quarter ended March 2023.Operating profit for the quarter ended March 2023 rose to 87.54 millions as compared to 59.30 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202203 202103 % Var
Sales 351.99 282.90 24.42 1367.49 1239.80 10.30 1239.80 1092.94 13.44
Other Income 12.56 12.78 -1.72 51.24 49.49 3.54 49.49 43.08 14.88
PBIDT 87.54 59.30 47.62 354.91 322.02 10.21 322.04 241.52 33.34
Interest 0.84 1.21 -30.58 3.67 4.34 -15.44 4.35 4.74 -8.23
PBDT 86.70 58.09 49.25 351.24 317.68 10.56 317.69 236.78 34.17
Depreciation 5.94 5.38 10.41 22.58 18.99 18.90 18.99 20.35 -6.68
PBT 80.76 52.71 53.22 328.66 298.69 10.03 298.70 216.43 38.01
TAX 17.22 18.23 -5.54 82.58 75.74 9.03 75.74 51.39 47.38
Deferred Tax 1.62 4.73 -65.75 -2.25 2.96 -176.01 2.96 -3.91 -175.70
PAT 63.54 34.48 84.28 246.08 222.95 10.37 222.96 165.04 35.09
Equity 44.13 45.89 -3.84 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 24.87 20.96 18.65 25.95 25.97 -0.08 25.98 22.10 17.54

Jenburkt Pharma Share Price

1050.40 24.80 (2.42%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×